Jazz Pharmaceuticals: Q1 Earnings Insights

Loading...
Loading...

Jazz Pharmaceuticals JAZZ reported its Q1 earnings results on Wednesday, May 4, 2022 at 05:05 PM.

Here's what investors need to know about the announcement.

Earnings

Jazz Pharmaceuticals missed estimated earnings by 2.61%, reporting an EPS of $3.73 versus an estimate of $3.83.

Revenue was up $206.14 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.58 which was followed by a 12.05% increase in the share price the next day.

Here's a look at Jazz Pharmaceuticals's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 3.63 3.31 3.42 3.74
EPS Actual 4.21 4.20 3.90 3.92
Revenue Estimate 865.88M 832.52M 735.62M 611.49M
Revenue Actual 896.73M 838.12M 751.81M 607.58M

To track all earnings releases for Jazz Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...